Participate in the development of a treatment pathway for people with Lumbar Spinal Stenosis


Osteopaths have been invited to take part in a study to develop a consensus treatment pathway for those with lumbar spinal stenosis by completing an online Delphi survey. The study is being conducted by the International Society for the Study of the Lumbar Spine (ISSLS) Taskforce on the Diagnosis and Management of Lumbar Spinal Stenosis.  

The ISSLS Taskforce would like clinicians and academics who have expertise/ experience in managing patients with Lumbar Spinal Stenosis (LSS) from a wide range of professional backgrounds and geographical regions to have the opportunity to take part. The aim of the study is to develop a consensus treatment pathway for people with LSS.

Participation is anonymous and entirely voluntary. This is the final questionnaire within the study, and you are welcome to participate whether or not you took part in Rounds 1 and Round 2. This Final Round survey asks participants for their views on the treatment algorithm that has been developed through the Delphi consensus process. The treatment algorithm can be found HERE.

Please feel free to share awareness of this study amongst professional colleagues with expertise in LSS research or clinical care who might be interested in participating. This final survey is considerably shorter than previous rounds, and will take around 10 minutes to complete. It will remain open until June 30th 2021 and can be accessed HERE.


If you require further information ahead of completing the study, please read the participation information provided by ISSLS below. 



  • What is the study about?

The aim is to develop an agreed treatment pathway algorithm for patients with lumbar spinal stenosis (LSS) based on research evidence and expert consensus. Expert opinion is required because of the limited research evidence currently available. The initial two rounds of this Delphi study included two surveys (which you may have participated in) in September/October 2019 and February/March 2020.  These focused on selecting appropriate treatments and sequencing of interventions for people with three different clinical phenotypes of LSS. From your survey responses and through internal expert and evidence-based consensus from the study team, a treatment algorithm has been finalised.  


  • What will I need to do if I participate?  

This is the last of three survey rounds.  As in previous rounds, the first few questions in this survey are about your clinical and academic background.  You will then be able to see the finalised treatment algorithm. We would like you to take some time looking at the algorithm, and then answer a few questions about the utility and applicability of the algorithm.  

This questionnaire is expected to take no more than 10 minutes to complete. We would love you to take part if you have clinical or research expertise in the diagnosis and/or treatment of people with LSS. Your participation is entirely voluntary. The questionnaire will remain open until June 30th 2021.


  • Why have I been approached? 

The researchers conducting this study are approaching participants with expertise and experience in managing patients with LSS.  We are distributing the survey via spinal research societies, professional bodies, or through local contacts and recommendations. These contact routes will be used for recruitment purposes only, and we will not have any way of knowing who completed each questionnaire. Please share this invitation with any colleagues who might be interested in participating. If this survey is not relevant to you (i.e. if you do not have experience in managing patients with LSS) please still feel free to forward the invitation to others who may have the relevant expertise/ experience.


  • What will happen next? 

Once we have analysed the results of this final round questionnaire, we will prepare a report of the findings for publication.


  • What are the risks? 

No significant risks are anticipated for participants other than a small amount of time required to participate in the survey questionnaire.  Your personal contact information will not be stored by us, and your completed questionnaire will be entirely anonymous, and stored electronically on a password protected storage drive in line with University of Leeds policy. Only anonymised data will be shared with external collaborators for the purposes of this study. You can withdraw from further participation in the study at any point, however we will not be able to withdraw data already collected from you, as your questionnaire responses cannot be traced to you. Your participation in this survey will be taken to imply consent to include your anonymised responses in our analyses and publication of results.


  • What is in it for you? 

The final outcome of this study will be an expert consensus on an evidence-based, standardised treatment pathway for patients with LSS symptoms.  We expect the results of this study to reduce variation in care for people with LSS and aid clinical decision-making.  We will publish the results of this study in a relevant peer-reviewed journal and share the findings at international spinal conferences.